Agenda

By the end of the congress, participants will be better able to:

• Integrate recent evidence and updates in clinical practice guidelines for managing obesity in children and adults to improve patient outcomes
• Evaluate and select individualized treatment options, including medical and lifestyle interventions for obesity
• Adopt comprehensive strategies for managing obesity-related complications
• Understand the diabetes spectrum and its treatment, applying high-quality evidence to improve patient outcomes in Type 1 and Type 2 Diabetes and diabetes in pregnancy
• Adapt diabetes management to meet individualized needs, addressing barriers and promoting lifestyle changes through motivational interviewing and advanced technologies
• Stay informed on the latest clinical practice guidelines, critically evaluate emerging evidence and technological advancements to apply to clinical practice

DUO DAY 1: THURSDAY, APRIL 23, 2026 (OBESITY UPDATE)
Time	Topic		Speaker(s)
8:00 am	Registration and Networking Breakfast
8:40 am	Breakfast Symposium
9:45 am	Welcome and Introductions		Dr. Jeffrey Habert Dr. Akshay Jain
PLENARY SESSION #1
10:00 am	Obesity Update: Top Five from 2025 Learning Objectives: • Discuss influential findings from recent clinical trials and studies inobesity management over the past year. • Assess clinical implications of emerging treatments and newsheadlines in obesity medicine to inform patient care.		Dr. Sean Wharton
10:20 am	Tailoring Diets to Metabolic Needs Learning Objectives: • Identify evidence-based dietary strategies tailored to specificmetabolic conditions such as PCOS, dyslipidemia, and liverdisease. • Assess targeted nutrition frameworks to optimize individualizedobesity management.		Ms. Alissa Steinberg
10:40 am	Rethinking Exercise: Benefits Beyond the Scale Learning Objectives: • Describe the metabolic and health benefits of physical activityindependent of weight loss. • Summarize feasible, accessible physical activity approaches forpeople living with obesity.		TBC
11:00 am	Panel Discussion and Q&A		All Faculty Plenary Session 1 Moderator: Dr. Jeffrey Habert
11:20 am	Networking Break and Lunch Buffet
11:45 am	Lunch Symposium
12:45 pm	Transition
PLENARY SESSION #2
12:50 pm	Presented by Obesity Matters – Through the Patient's Eyes Learning Objectives: • Recognize diverse patient experiences with bariatric surgery,pharmacotherapy, and non-response to treatment. • Apply patient-centered insights to enhance empathy,communication, and shared decision-making in obesity care.		Moderator: Dr. Sandy Van Two patient partners
1:10 pm	The New Canadian Obesity Treatment Algorithm: What You Need to Know Learning Objectives: • Interpret updates to the Canadian pharmacotherapy chapter andapply algorithm-based tools for clinical decision-making. • Evaluate the place in treatment landscape, efficacy profiles, andsequencing considerations for different weight managementtherapies.		Dr. Akshay Jain
1:50 pm	Panel Discussion and Q&A		All Faculty Plenary Session 2 Moderator: Dr. Jill Trinacty
2:05 pm	Health Break
2:30 pm	Afternoon Symposium
PLENARY SESSION #3
3:35 pm	Pediatric Obesity Guidelines: Communication, Care, and Clinical Choices Learning Objectives: • Implement guideline-based approaches for assessment,treatment selection, and monitoring in pediatric obesity. • Use stigma-aware, developmentally appropriate communicationstrategies when counselling children and families.		Dr. Elizabeth Dettmer
3:55 pm	Family Dynamics in Childhood Obesity Learning Objectives: • Evaluate family-centered obesity interventions, including socialwork integration and family reset models. • Recognize strategies to support healthy family dynamics andsustainable behavior change in pediatric obesity.		Dr. Sanjukta Basak
4:15 pm	Obesity and Reproductive Health: A Woman’s Journey Learning Objectives: • Explain the impact of obesity across reproductive stages, includingmenstrual health, fertility, pregnancy, and postpartum outcomes. • Review evidence on GLP-1-associated fertility considerations andintegrate guidance for patients pursuing IVF or reproductive care.		Dr. Alyse Goldberg
4:35 pm	Panel Discussion and Q&A		All Faculty Plenary Session 3 Moderator: Dr. Sandy Van
4:55 pm	Closing Remarks Day 1 (OU)		Dr. Jeffrey Habert Dr. Akshay Jain
End of Day 1

DUO DAY 2: FRIDAY, APRIL 24, 2026 (DIABETES UPDATE)
Time	Topic		Speaker(s)
8:00 am	Registration and Networking Breakfast
8:50 am	Breakfast Symposium
9:55 am	Welcome and Introductions		Dr. Akshay Jain Dr. Alanna Weisman
PLENARY SESSION #1
10:10 am	Top 5 Trials Reshaping Diabetes Care in 2025/2026 Learning Objectives: • Evaluate the clinical implications of recent high-impactdiabetes trials, including SURPASS CVOT, STRIDE, REDEFINE, FLOW, and emerging T1D therapies. • Translate key findings from these studies into evidence-basedupdates for diabetes management.		Dr. Alice Cheng
10:30 am	MASLD in T2D: What’s New in the Guidelines? Learning Objectives: • Interpret updated MASLD guidelines and applyrecommendations for optimal screening in individuals with Type 2 diabetes. • Implement evidence-based management strategies for MASLDwithin diabetes care.		Dr. Giada Sebastiani
10:50 am	Beyond Statins: New Lipid Tools & Lp(a) Testing Learning Objectives: • Identify clinical scenarios where bempedoic acid, inclisiran,and icosapent ethyl should be considered for lipid optimization. • Recognize the importance of Lp(a) testing in managingcardiovascular risk.		Dr. George Thanassoulis
11:10 am	Panel Discussion and Q&A		All Faculty Plenary Session 1 Moderator: Dr. Alanna Weisman
11:30 am	Health Break and Lunch Buffet
11:55 am	Lunch Symposium
PLENARY SESSION #2
1:00 pm	Muscle Matters with GLP-1 Therapy Learning Objectives: • Assess current evidence on sarcopenia and muscle lossassociated with GLP-1 RA therapy. • Apply practical strategies to maintain muscle health during GLP-1-associated weight reduction in clinical practice.		Dr. Akshay Jain
1:20 pm	Gastroparesis: Practical Diagnosis & Management Learning Objectives: • Identify effective approaches for screening and diagnosinggastroparesis in clinical practice. • Evaluate the safe use of GLP-1 therapies and implementtreatment strategies for patients with gastroparesis.		Dr. Yvonne Tse
1:50 pm	Applying Evidence-Based Nutrition in Diabetes Learning Objectives: • Summarize key dietary recommendations for diabetes,including macronutrient distribution and meal-planning approaches. • Explain how GLP-1 RA therapy influences appetite, nutrientintake, and GI tolerance, and discuss strategies to maintain nutritional adequacy.		Ms. Tara Koyama
2:10 pm	Panel Discussion and Q&A		All Faculty Plenary Session 2 Moderator: Dr. Jeff Habert
2:30 pm	Health Break
PLENARY SESSION #3
2:55 pm	From Conception to Delivery: Managing Type 2 Diabetes During Pregnancy Learning Objectives: • Apply evidence-based pre-conception strategies, including A1coptimization, to reduce pregnancy-related risks. • Evaluate the role of metformin, CGMs, and post-deliveryconsiderations in managing type 2 diabetes during pregnancy.		Dr. Sonia Butalia
3:15 pm	Diabetes Care for Older Adults: What’s Ahead Learning Objectives: • Interpret anticipated Diabetes Canada guideline updatesrelevant to older individuals with diabetes. • Incorporate age-specific considerations into therapeuticdecision-making to reduce adverse outcomes.		Dr. Iliana Lega
3:35 pm	Panel Discussion and Q&A		All Faculty Plenary Session 3 Moderator: Dr. Stavroula Christopoulos
3:50 pm	Closing Remarks Day 2 (DU)		Dr. Akshay Jain Dr. Alanna Weisman
End of Day 2

DUO DAY 3: SATURDAY, APRIL 25, 2026 (DIABETES UPDATE)
Time	Topic			Speaker(s)
9:00 am	Networking Breakfast
9:30 am	Welcome and Introductions			Dr. Akshay Jain Dr. Alanna Weisman
9:45 am	Keynote
PLENARY SESSION #4 - STREAM 1			STREAM 2
10:25 am	Insights to BETTER Care in T1D Learning Objectives: • Summarize key findingsfrom the BETTER Registry and their implications for type 1 diabetes care. • Utilize available registry-supported resources to enhance patient and provider decision-making.	Ms. Anne Sophie Brazeau	Protecting the Kidneys in Diabetes: What, When, and Who Learning Objectives: • Interpret UACR and otherrenal markers to assess kidney health in diabetes. • Select and sequencemedications with renal benefit to slow disease progression.	Dr. Phil McFarlane
10:45 am	Defining the Roles of SGLT2i and GLP-1RA in T1D Care Learning Objectives: • Evaluate the role of SGLT2inhibitors and GLP-1 receptor agonists as adjuncts to insulin in pump and non-pump users. • Apply clinicalconsiderations to optimize safety and efficacy when using adjunctive therapies in T1D.	Dr. Alanna Weisman	No Rest in Diabetes: Impact of Insomnia Learning Objectives: • Assess the impact ofinsomnia on diabetes outcomes using ADA guidance and supporting data. • Distinguish available sleeptherapies, including DORAs, and implement practical management strategies.	Dr. James Kim
11:05 am	Panel Discussion and Q&A	All Faculty Moderator: Dr. Stavroula Christopoulos	Panel Discussion and Q&A	All Faculty Moderator: Ms. Lisa Maks
11:20 am	Health Break
11:40 am	AID in Action: Complex Cases with Insulin Learning Objectives: • Apply AID systemprinciples to challengingclinical scenarios,including surgery andsteroid use. • Discuss methods foroptimizing AID use inpatients requiring highinsulin doses	TBC	Supporting Patients on GLP-1 Therapy: Practical Guidance Learning Objectives: • Provide counsellingstrategies for initiating andmaintaining GLP-1 therapies,including chronic-useframing. • Identify and addresscommon patient concernswith evidence-basedguidance.	Dr. Jeff Habert
12:00 pm	The Future of T1D Therapies: Teplizumab and Cell-Based Therapies Learning Objectives: • Identify appropriatecandidates for teplizumaband navigate access andadministrationconsiderations in Canada. • Review the currentlandscape of cell-basedtherapies and theirreadiness for clinicalimplementation.	Dr. Bruce Perkins	Voiding Dysfunction in Diabetes: Early Signs & Solutions Learning Objectives: • Differentiate voidingdysfunction as a potentialearly marker of dysglycemiaand neuropathy. • Develop management plansfor bladder dysfunction in thecontext of diabetesprogression.	Dr. Lysanne Campeau
12:20 pm	Panel Discussion and Q&A	All Faculty Moderator: Dr. Sonia Butalia	Panel Discussion and Q&A	All Faculty Moderator: Dr. Akshay Jain
12:35 pm	Networking Break / Lunch Buffet
1:00 pm	Lunch Symposium
PLENARY SESSION #5
2:05 pm	Complex Case Panel Discussion			Planning Committee
2:30 pm	Closing Remarks Day 3 (DU)			Dr. Akshay Jain Dr. Alanna Weisman
End of DUO 2026